Page last updated: 2024-08-24

mibefradil and Leukemia

mibefradil has been researched along with Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Huang, W; Lu, C; Ouyang, S; Wu, Y	1

Other Studies

1 other study(ies) available for mibefradil and Leukemia

Article	Year
T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines. Journal of experimental & clinical cancer research : CR, 2015, May-21, Volume: 34 Topics: Apoptosis; Benzimidazoles; Calcium Channel Blockers; Calcium Channels, T-Type; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopropanes; Endoplasmic Reticulum; Humans; Leukemia; Leukocytes, Mononuclear; MAP Kinase Signaling System; Mibefradil; Naphthalenes	2015

Article

Year

T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines.

Journal of experimental & clinical cancer research : CR, 2015, May-21, Volume: 34

Topics: Apoptosis; Benzimidazoles; Calcium Channel Blockers; Calcium Channels, T-Type; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopropanes; Endoplasmic Reticulum; Humans; Leukemia; Leukocytes, Mononuclear; MAP Kinase Signaling System; Mibefradil; Naphthalenes

2015